Amygdalin as a chemoprotective agent in co-treatment with cisplatin

HIGHLIGHTS

• who: September and collaborators from the United Kingdom Damanhour University, Egypt have published the research: Amygdalin as a chemoprotective agent in co-treatment with cisplatin, in the Journal: (JOURNAL)
• what: The authors used a combination treatment of 15 u03bcu039c cisplatin and 10 mM amygdalin both in normal MCF12F cells as well as FBS, to further evaluate the safety of amygdalin on normal cells as well as its cyto-protective abilities in the presence of anticancer treatments. In the last decade, progress studies aim to identify the potential of combinational strategies using one or more natural . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.